A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis

Radiation Research

Volumn 155, Issue 1, 2001, Pages 201-207

  Chang, Chia Cheng ^a,b   Sun, Wei ^a   Cruz, Angela ^a   Saitoh, Maki ^a   Tai, Mei Hui ^a   Trosko, James E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL; BREAST; BREAST TUMOR; CELL TRANSFORMATION; CYTOLOGY; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVIEW; STEM CELL;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; STEM CELLS; TELOMERASE;

EID: 0035219156     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2     Document Type: Article

References (73)

1. B. Vogelstein, E. R. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger, M. Leppert, Y. Nakamura, R. White, A. M. Smits and J. L. Bos, Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319, 525-532 (1988).
2. I. B. Weinstein, S. Gattoni-Celli, P. Kirchmeler, M. Lambert, W. Hsiao, J. Backer and A. Jeffray, Multistage carcinogenesis involves multiple mechanisms. J. Cell Physiol. 3, 127-137 (1984).
3. W. B. Murrill, N. M. Brown, J. X. Zhang, P. A. Manzolillo, S. Barnes and C. A. Lamartiniere, Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457 (1996).
4. W. A. Fritz, L. Coward, J. Wang and C. A. Lamartiniere, Dietary genistein: Perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19, 2151-2158 (1998).
5. D. E. Wazer, X. L. Liu, Q. Chu, Q. Gao and V. Band, Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci. USA 92, 3687-3691 (1995).
6. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
7. W. Sun, K. S. Kang, I. Morita, J. E. Trosko and C. C. Chang, High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization. Cancer Res. 59, 6118-6123 (1999).
8. S. H. Sigal, S. Brill, A. S. Fiorino and L. M. Reid, The liver as a stem cell and lineage system. Am. J. Physiol. 263, G139-G148 (1992).
9. H. Varmus and R. A. Weinberg, In Genes and the Biology of Cancer, pp. 38-39. Scientific American Library, New York, 1993.
10. H. Yang, Chemotherapeutic and chemopreventive roles of sphinolipids in human breast cancer. M.S. Thesis, Michigan State University, 1999.
11. C. L. Markert, Neoplasia: A disease of cell differentiation. Cancer Res. 28, 1908-1914 (1968).
12. V. R. Potter, Phenotypic diversity in experimental hepatomas: The concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br. J. Cancer 38, 1-23 (1978).
13. C. L. Sawyers, C. T. Denny and O. N. Witte, Leukemia and the disruption of normal hematopoiesis. Cell 64, 337-350 (1991).
14. S. Yarkoni, M. Lishner, I. Tangi, A. Nagler and G. H. Lorberboum, B-cell non-Hodgkin's lymphoma: Evidence for the t (14;18) translocation in all hematopoietic cell lineages. J. Natl. Cancer Inst. 88, 973-979 (1996).
15. F. Mandelli, G. Avvisati and M. Tribalto, Biology and treatment of multiple myeloma. Curr. Opin. Oncol. 4, 73-86 (1992).
16. C. S. Potten, The role of apoptosis and apoptosis regulatory genes in stem cell homeostasis and carcinogenesis risk in the gastrointestinal tract. In Radiation Research, Vol. 2 (M. Moriarty, C. Mothersill, C. Seymour, M. Edington, J. F. Ward and R. J. M. Fry, Eds.), pp. 583-586. Allen Press, Lawrence, KS, 2000.
17. B. MacMahon, P. Cole, T. M. Lin, C. R. Lowe, A. P. Mirra, B. Ravnihar, E. J. Salber, V. G. Valaoras and S. Yuasa, Age at first birth and breast cancer risk. Bull. WHO 43, 209-221 (1970).
18. R. Love and V. G. Vogel, Breast cancer prevention strategies. Oncology (Huntingt.) 11, 161-168 (1997).
19. L. Canty, Breast cancer risk: Protective effect of an early first full-term pregnancy versus increased risk of induced abortion. Oncol. Nurs. Forum 24, 1025-1031 (1997).
20. J. Cairns, Mutation selection and the natural history of cancer. Nature 255, 197-200 (1975).
21. I. H. Russo, M. Koszalka and J. Russo, Human chorionic gonadotropin and rat mammary cancer prevention. J. Natl. Cancer Inst. 82, 1286-1289 (1990).
22. R. C. Guzman, J. Yang, L. Rajkumar, G. Thordarson, X. Chen and S. Nandi, Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. USA 96, 2520-2525 (1999).
23. I. H. Russo, M. Koszalka and J. Russo, Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br. J. Cancer 64, 481-484 (1991).
24. W. B. Murrill, N. M. Brown, J. X. Zhang, P. A. Manzolillo, S. Barnes and C. A. Lamartiniere, Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457 (1996).
25. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
26. C. C. Chang, C. J. Liu, W. Sun, M. Saitoh and J. E. Trosko, Roles of ionizing radiation in neoplastic transformation of human breast epithelial cells. In Radiation Research, Vol. 2 (M. Moriarty, C. Mothersill, C. Seymour, M. Edington, J. F. Ward and R. J. M. Fry, Eds.), pp. 576-579. Allen Press, Lawrence, KS, 2000.
27. J. D. Iglehart, M. H. Kraus, B. C. Langton, G. Huper, B. J. Kerns and J. R. Marks, Increased erbB2 gene copies and expression in multiple stages of breast cancer. Cancer Res. 50, 6701-6707 (1990).
28. I. U. Ali, G. Merlo, R. Callahan and R. Lindereau, The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. Oncogene 4, 89-92 (1989).
29. M. J. Van de Vijver and R. Nusse, The molecular biology of breast cancer. Biochim. Biophys. Acta 1072, 33-50 (1991).
30. A. C. Lammie, V. Fantal, R. Smith, E. Schuuning, S. Brooks, R. Michalides, C. Dickson, A. Arnold and G. Peters, Dlls 289, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cells and mammary carcinomas and linked to bcl-1. Oncogene 6, 439-444 (1991).
31. K. Keyomarsi and A. B. Pardee, Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90, 1112-1116 (1993).
32. C. S. Cropp, R. Lidereau, G. Campbell, M. H. Champene and R. Callahan, Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: Two additional regions identified. Proc. Natl. Acad. Sci. USA 87, 7737-7741 (1990).
33. T. Sato, F. Akiyama, G. Sakamoto, F. Kasumi and Y. Nakayama, Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 52, 5794-5799 (1991).
34. T. Iwai, S. Yokota, M. Nakao, N. Nakazawa, M. Taniwaki, T. Kimura, Y. Sonoda, H. Kaneko, T. Okuda and T. Fujimoto, Frequent aberration of FHIT gene expression in acute leukemias. Cancer Res. 58, 5182-5187 (1998).
35. C. C. Clark, I. Cohen, I. Eichstetter, L. A. Canniggaro, J. D. McPherson, J. J. Wasmuth and R. V. lozzo, Molecular cloning of human proto-oncogene wnt-5a and mapping of the gene (wnt-5a) to chromosome 3p14-p21. Genomics 18, 249-260 (1993).
36. kip2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA 93, 3026-3030 (1996).
37. ink4a in human cancer. Proc. Natl. Acad. Sci. USA 91, 11045-11049 (1994).
38. A. Zou, A. Anisowicz, M. J. C. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi, E. Sefter and R. Sager, Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529 (1994).
39. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose and R. Parsons, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275, 1943-1947 (1997).
40. M. Swift, D. Morrell, R. B. Massey and C. L. Chase, Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med. 325, 1831-1836 (1991).
41. P. Athma, R. Rappaport and M. Swift, Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92, 130-134 (1996).
42. M. Jung, A. Kondeatyev, S. A. Lee, A. Dimtchev and A. Dritschilo, ATM gene product phosphorylation IKB-α. Cancer Res. 57, 24-27 (1997).
43. S. Banin, L. Moyal, S-Y. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss and Y. Ziv, Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998).
44. C. E. Canman, D-S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan and J. D. Siliciano, Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
45. I. Vorechovsky, D. Rasio, L. Luo, C. Monaco, L. Hammarstrom, A. D. Webster, J. Zaloudik, G. Barbanti-Brodani, M. James and M. Negrini, The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res. 56, 2726-2732 (1996).
46. P. G. Rio, D. Pernin, J. O. Bay, E. Albuisson, F. Kwiatkowski, M. DeLatour, D. J. Bernard-Gallon and Y-J. Bignon, Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int. J. Oncol. 13, 849-853 (1998).
47. WAF1/CiP1. Nature 389, 187-190 (1997).
48. Q. Gao, S. H. Hauser, X-L. Liu, D. E. Wazer, H. Madoc-Jones and V. Band, Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res. 56, 3129-3133 (1996).
49. Y. Cao, Q. Gao, D. E. Wazer and V. Band, Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cancer Res. 57, 5584-5589 (1997).
50. his). Oncogene 12, 715-725 (1996).
51. S. J. Done, N. C. R. Anneson, H. Ozulik, M. Redston and I. L. Andrulls, p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasia. Cancer Res. 58, 785-789 (1998).
52. J. W. Shay, W. E. Wright and H. Werbin, Denning the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072, 1-7 (1991).
53. E. Hiyama, L. Gollahon, T. Kataoka, K. Kuroi, T. Yokoyama, A. F. Gazdar, K. Hiyama, M. A. Piatyszek and J. W. Shay, Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88, 116-122 (1996).
54. J. E. Trosko, C. C. Chang and B. V. Madhukar, Modulation of intercellular communication during radiation and chemical carcinogenesis. Radiat. Res. 123, 241-251 (1990).
55. R. Ullrich, Radiation-induced instability and its relationship to radiation carcinogenesis. In Radiation Research, Vol. 2 (M. Moriarty, C. Mothersill, C. Seymour, M. Edington, J. E Ward and R. J. M. Fry, Eds.), pp. 508-509. Allen Press, Lawrence, KS, 2000.
56. M. R. Stampfer and J. C. Bartley, Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA 82, 2394-2398 (1985).
57. C. Y. Kao, K. Nomata, C. S. Oakley, C. W. Welsch and C. C. Chang. Two types of normal human breast epithelial cells derived from reduction mammoplasty: Phenotypic characterization and response to SV40 transfection. Carcinogenesis 16, 531-538 (1995).
58. D. E. Wazer, Q. Chu, X. L. Liu, Q. Gao, H. Safaii and V. Band, Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol. 14, 2468-2478 (1994).
59. R. Clark, M. R. Stampfer, R. Milley, E. O'Rourke, K. H. Wallen, M. Kriegler, J. Kopplin and F. McCormick, Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Res. 48, 4689-4694 (1988).
60. G. Calaf, Q. Tahin, M. E. Alvarado, S. Estrada, T. Cox and J. Russo, Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogen and c-Ha-ras transfection. Breast Cancer Res. Treat. 29, 169-177 (1993).
61. G. Calaf and J. Russo, Transformation of human breast epithelial cells by chemical carcinogen. Carcinogenesis 14, 483-492 (1993).
62. C. Y. Kao, C. S. Oakley, C. W. Welsch and C. C. Chang, Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty. In Vitro Cell. Dev. Biol. 33, 282-288 (1997).
63. c-erbB2/neu in tumorigenicity induced by x-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen. 21, 225-233 (1998).
64. K. S. Kang, I. Morita, A. Cruz, Y. I. Jeon, J. E. Trosko and C. C. Chang, Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 18, 251-257 (1997).
65. C. C. Chang, J. E. Trosko, M. H. El-Fouly, R. Gibson-D'Ambrosio and S. D'Ambrosio, Contact insensitivity of a subpopulation of normal human fetal kidney epithelial cells and human carcinoma cell lines. Cancer Res. 47, 1634-1645 (1987).
66. M. Matic, I. N. Petrov, S. H. Chen, C. Wang, S. D. Dimitrijevich and J. M. Wolosin, Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 61, 251-260 (1997).
67. K. S. Kang, C. C. Chang and J. E. Trosko, Modulation of gap junctional intercellular communication during human breast stem cell differentiation and immortalization. In Gap Junctions (R. Werner, Ed.), pp. 347-351. IOS Press, Amsterdam, 1998.
68. I. H. Russo and J. Russo, Roles of hormones in mammary cancer initiation and progression. J. Mamm. Gland Biol. Neoplasia 3, 49-61 (1998).
69. N. D. Kim, K. J. Paik and K. H. Clifton, Inhibitory effects of retinoids on development of squamous metaplasia in rat mammary epithelial organoids cultured in Matrigel. Cancer Lett. 110, 217-223 (1996).
70. O. W. Petersen, L. Ronnov-Jessen, A. R. Howlett and M. J. Bissell, Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064-9068 (1992).
71. N. W. Kim, M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich and J. W. Shay, Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
72. C. D. Belair, T. R. Yeager, P. M. Lopez and C. A. Reznikoff, Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677-13682 (1997).
73. C. Y. Hsieh and C. C. Chang, Stem cell differentiation and reduction as a potential mechanism for chemoprevention of breast cancer. Chinese Pharm. J. 51, 15-30 (1999).